<DOC>
<DOCNO>EP-0639182</DOCNO> 
<TEXT>
<INVENTION-TITLE>
QUINOLINE DERIVATIVES.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3147	A61K3147	A61P2900	A61P2900	A61P3500	A61P3500	A61P3700	A61P3700	C07D21500	C07D21536	C07D21554	C07D21556	C07D40100	C07D40104	C07D40106	C07D40112	C07D40500	C07D40512	C07D41300	C07D41304	C07D41306	C07D41700	C07D41706	C07D41712	C07D47100	C07D47106	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61P	A61P	A61P	A61P	A61P	A61P	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61P29	A61P29	A61P35	A61P35	A61P37	A61P37	C07D215	C07D215	C07D215	C07D215	C07D401	C07D401	C07D401	C07D401	C07D405	C07D405	C07D413	C07D413	C07D413	C07D417	C07D417	C07D417	C07D471	C07D471	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Quinoline derivatives of formula (I), wherein R
<
1
>
 is lower alkyl or aryl which may have suitable substituent(s), R
<
2
>
 is hydroxy, protected hydroxy, lower alkoxy, etc., R
<
3
>
 is hydrogen, lower alkyl, lower alkoxy(lower)- alkyl or ar(lower)alkyl and R
<
8
>
 is hydrogen, or R
<
3
>
 and R8 are linked together to form lower alkylene, R
<
4
>
 is an organic group, Z is O or S, and n is 0, 1 or 2; and pharmaceutically acceptable salts thereof which are useful as a medicament.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
FUJISAWA PHARMACEUTICAL CO
</APPLICANT-NAME>
<APPLICANT-NAME>
FUJISAWA PHARMACEUTICAL CO., LTD.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
MATSUO MASAAKI
</INVENTOR-NAME>
<INVENTOR-NAME>
NAKAMURA KATSUYA
</INVENTOR-NAME>
<INVENTOR-NAME>
SPEARS GLEN W
</INVENTOR-NAME>
<INVENTOR-NAME>
TSUJI KIYOSHI
</INVENTOR-NAME>
<INVENTOR-NAME>
MATSUO, MASAAKI
</INVENTOR-NAME>
<INVENTOR-NAME>
NAKAMURA, KATSUYA
</INVENTOR-NAME>
<INVENTOR-NAME>
SPEARS, GLEN W.
</INVENTOR-NAME>
<INVENTOR-NAME>
TSUJI, KIYOSHI
</INVENTOR-NAME>
</INVENTORS>
<DESCRIPTION>
 DESCRIPTIONQUINOLINE DERIVATIVESTECHNICAL FIELDThis invention relates to new quinoline derivatives and pharmaceutically acceptable salts thereof which are useful as a medicament.BACKGROUND ARTSome guinoline derivatives have been known as described, for example, in U.S. Patent 4,547,511 and U.S. Patent 4,127,574.DISCLOSURE OF INVENTIONThis invention relates to new guinoline derivatives. More particularly, this invention relates to new guinoline derivatives and pharmaceutically acceptable salts thereof which have pharmacological activities, processes for preparation thereof, a pharmaceutical composition comprising the same and a use of the same.Accordingly, one object of this invention is to provide the new and useful guinoline derivatives and pharmaceutically acceptable salts thereof which possess a strong immunomodulating activity (e.g. an inhibitory activity on the production of an autoantibody, etc. ) , anti-inflammatory activity and anti-cancer activity. Another object of this invention is to provide processes for preparation of the guinoline derivatives and salts thereof.A further object of this invention is to provide a pharmaceutical composition comprising said guinoline derivatives or a pharmaceutically acceptable salt thereof. Still further object of this invention is to provide 

 a use of said guinoline derivatives or a pharmaceutically acceptable salt thereof as a medicament for the treatment and/or prevention of inflammatory conditions, various pains, collagen diseases, autoimmune diseases, various immunity diseases, cancer and the like in human being and animals.The object guinoline derivatives of the present invention are novel and can be represented by the following general formula (I) :wherein R is lower alkyl or aryl which may have suitable substituent(s) ,2R is hydroxy, protected hydroxy, lower alkoxy, halogen, amino, substituted amino, mercapto or protected mercapto, 3 R is hydrogen, lower alkyl, lower alkoxy(lower)- alkyl or ar(lower)alkyl andQR is hydrogen, orR 3 and R8 are linked together to form lower alkylene,R 4 i.s an organic group, Z is O or S, and n is 0, 1 or 2.The object compound (I) of the present invention can be prepared by the following processes. 

 or a sa t t ereof(la) or a salt thereofProcess (2)(lb) or a salt thereof 

 I oxidation(Ic) or a salt thereofProcess (3)(Id) or its reactive derivative at the carboxy group or a salt thereof[ Amidation reaction(Ie) or a salt thereof 

 Process ( 4 )(If) or a salt thereofElimination reaction of the carboxy protective group
</DESCRIPTION>
<CLAIMS>
C L A I M S
A compound of the formula :
wherein R is lower alkyl or aryl which may have suitable substituent(s) , 2 R is hydroxy, protected hydroxy, lower alkoxy, halogen, amino, substituted amino, mercapto or protected mercapto, 3 R is hydrogen, lower alkyl, lower alkoxy(lower)alkyl or ar(lower)alkyl and R is hydrogen, or
3 8 " R and R are linked together to form lower alkylene, R 4 i.s an organic group,
2 is O or S, and n is 0, 1 or 2, and pharmaceutically acceptable salts thereof.
A compound of claim 1, wherein •
R is lower alkyl, or phenyl which may have halogen,
2 R is hydroxy, acyloxy, lower alkoxy, halogen, amino, lower alkylamino, protected amino, mercapto or acylthio,
R is hydrogen, lower alkyl, lower alkoxy(lower)alkyl, or phenyl(lower)alkyl and o R is hydrogen, or 


 -98-
R 3 and R8 are linked together to form lower alkylene, and 4 R is acyl, carboxy, ar(lower)alkylsulfinyl, ar(lower)alkylthio, cyano, or heterocyclic group which may have suitable substituent(s) .
3. A compound of claim 2, wherein
R is lower alkyl, phenyl or halophenyl,
2 R is hydroxy, acyloxy, lower alkoxy, halogen, amino, lower alkylamino, acylamino, mercapto or lower alkanoylthio, and 4 R is carbamoyl which may be substituted with one or two suitable substituent(s) selected from the group consisting of lower alkyl; phenyl which may have 1 to 3 suitable substituent(s) selected from the group consisting of lower alkyl, halogen, lower alkoxy, lower alkylthio, acyl, di(lower)alkylamino, cyano, mono(or di or tri)halo(lower)alkyl, mono(or di or tri)halo(lower)alkoxy, carboxy, protected carboxy, nitro, amino and acylamino; heterocyclic group which may have lower alkyl; phenyl(lower)alkyl; lower cycloalkyl and a group of the formula :
(in which A is lower alkylene) ; thiocarbamoyl which may be substituted with one or two suitable substituent(s) selected from the group consisting of lower alkyl and aryl; lower alkoxycarbonyl; 


 -99-
aminosulfonyl which may be substituted with one or two suitable substituent(s) selected from the group consisting of lower alkyl and aryl; aroyl; ar(lower)cycloalkylcarbonyl; ar(lower)alkylsulfonyl; heterocycliccarbonyl; carboxy; ar(lower)alkylsulfinyl; ar(lower)alkylthio; cyano; or heterocyclic group which may have lower alkyl or aryl.
4. A compound of claim 3, wherein 4 R is carbamoyl which may be substituted with one or two suitable substituent(s) selected from the group consisting of lower alkyl, phenyl, mono(or di)(lower)alkylphenyl , mono(or di)halophenyl, (lower)alkoxyphenyl, lower alkylthiophenyl, lower alkanoylphenyl,
N,N-di(lower)alkylaminσphenyl, cyanophenyl, trihalo(lower)alkylphenyl, trihalo(lower)alkoxyphenyl, carboxyphenyl, lower alkoxycarbonylphenyl, nitrophenyl, aminophenyl, lower alkanoylaminophenyl, pyridyl, lower alkylpyrazolyl, pyrrolyl, thiazolyl, thiadiazolyl, benzodioxolyl, phenyl(lower)alkyl, lower cycloalkyl and indanyl; thiocarbamoyl which may be substituted with one or two suitable substituent(s) selected from the group consisting of lower alkyl and phenyl; lower alkoxycarbonyl; aminosulfonyl which may be substituted with one or two suitable substituent(s) selected from the group consisting of lower alkyl and phenyl; benzoyl; phenyl(lower)cycloalkylcarbonyl; phenyl(lower)alkylsulfonyl; indolinylcarbonyl;- 


 -100-
dihydrobenzoxazinylcarbonyl; dihydrobenzothiazinylcarbonyl; carboxy; phenyl(lower)alkylsulfinyl; phenyl(lower)alkylthio; cyano; imidazolinyl or tetrazolyl, each of which may have aryl; oxadiazolyl which may have aryl; or benzimidazolyl, guinolyl or isoguinolyl, each of which may have lower alkyl.
5.. A compound of claim 4, wherein 4 R is carbamoyl which may be substituted with one or two suitable substituent(s) selected from the group consisting of lower alkyl, phenyl, mono(or di) (lower)alkylphenyl, mono(or di)halophenyl, (lower)alkoxyphenyl, lower alkylthiophenyl, lower alkanoylphenyl, ,N-di(lower)alkylaminophenyl, cyanophenyl, trihalo(lower)alkylphenyl, trihalo(lower)alkoxyphenyl, carboxyphenyl, lower alkoxycarbonylphenyl, nitrophenyl, aminophenyl, lower alkanoylaminophenyl, pyridyl, lower alkylpyrazolyl, pyrrolyl, thiazolyl, thiadiazolyl, 1,3-benzodioxolyl, phenyl(lower)alkyl, lower cycloalkyl and indan-2-yl; thiocarbamoyl which may be substituted with one or two suitable substituent(s) selected from the group consisting of lower alkyl and phenyl; lower alkoxycarbonyl; aminosulfonyl which may be substituted with one or two suitable substituent(s) selected from the group consisting of lower alkyl and phenyl; benzoyl; phenyl(lower)cycloalkylcarbonyl; phenyl(lower)alkylsulfonyl; indolinylcarbonyl,
*

 dihydrobenzoxazinylcarbonyl; dihydrobenzothiazinylcarbonyl; carboxy; phenyl(lower)alkylsulfinyl; phenyl(lower)alkylthio; cyano; imidazolinyl; phenylimidazolinyl; tetrazolyl; phenyltetrazolyl; oxadiazolyl; phenyloxadiazolyl; benzimidazolyl; lower alkylbenzimidazolyl; quinolyl; or isoquinolyl.
6. A compound of claim 5, wherein
R is lower alkyl, phenyl or halophenyl
R 2 i.s hydroxy,
3 R is lower alkyl and
R is hydrogen, or R 3 and R8 are linked together to form lower alkylene,
R 4 i.s carbamoyl which may have one or two suitable substituent(s) selected from the group consisting of lower alkyl, phenyl, mono(or di)halophenyl, lower alkoxyphenyl, lower alkylphenyl, cyanophenyl, pyrrolyl, trihalo(lower)alkoxyphenyl, trihalo(lower)alkylphenyl, nitrophenyl, aminophenyl, 1,3-benzodioxolyl and lower alkanoylaminophenyl, or phenyl(lower)cycloalkylcarbonyl,
Z is 0 or S, and n is 0 or 1.
7. A compound of claim 6, which is selected from the group consisting of
(1) l-Methyl-2-oxo-3-{N-(4-fluorophenyl)-N- methylcarbamoyl}-4-hydroxy-6-methγlthio-l,2- dihydroquinoline,
(2) l-Methyl-2-oxo~3-{N-(4-methoxyphenyl)-N- 


 methylcarbamoyl}-4-hydroxy-6-methylthio-1,2- dihydroquinoline,
(3) l-Methyl-2-oxo-3-(N-methyl-N-phenylcarbamoyl)-4- hydroxy-6-methylsulfinyl-1,2-dihydroquinoline,
(4) l-Methyl-2-oxo-3-[N-methyl-N-phenylamino(thio- carbonyl) ]-4-hydroxy-6-methylthio-1,2-dihydro¬ quinoline,
(5) l-Methγl-2-oxo-3-(N-methyl-N-phenylcarbamoyl)-4- hydroxy-6-ethylthio-1,2-dihydroquinoline,
(6) 1-Methyl-2-oxo-3-[N-methyl-N-phenylcarbamoyl]-4- hydroxy-6-phenylthio-1,2-dihydroquinoline ,
(7) l-Methyl-2-oxo-3-{N-(2-methylphenyl)carbamoyl}- 4-hydroxy-6-methylthio-l,2-dihydroquinoline,
(8) l-Methyl-2-oxo-3-(N-ethyl-N-phenylcarbamoyl)-
4-hydroxy-6-methylthio-1,2-dihydroquinoline,
(9) 4-Oxo-5-(N-methyl-N-phenylcarbamoyl)-6-hydroxy- 8-methγlthio-l,2-dihγdro-4H-pyrrolo[3,2,1-ij]- quinoline,
(10) l-Methyl-2-thioxo-3-(N-methyl-N-phenyl¬ carbamoyl)-4-hydroxγ-6-methylthio-l,2- dihydroguinoline
/
(11) l-Methyl-2-oxo-3-(N-methyl-N-phenylcarbamoyl)-4- hγdroxγ-6-phenylsulfinyl-1,2-dihydroquinoline,
(12) l-Methyl-2-oxo-3-(N-methyl-N-phenylcarbamoyl)- 4-hydroxy-6-(4-fluorophenylthio)-l,2- 


 dihydroquinoline,
( 13 ) l-Methyl-2-oxo-3-(1-phenyl-l-cyclopropγl- carbonyl)-4-hydroxy-6-methylthio-1,2-dihydro¬ quinoline,
(14) l-Methyl-2-oxo-3-[N-methyl-N-(1-pyrrolyl)- carbamoyl]-4-hydroxy-6-methylthio-1,2-dihydro¬ quinoline,
(15) l-Methyl-2-oxo-3-[N-(4-cyanophenyl) -N-methyl¬ carbamoyl]-4-hydroxy-6-methylthio-1,2-dihydro¬ guinoline,
(16) l-Methyl-2-oxo-3-[N-methyl-N-{4-(trifluoro¬ methoxy)phenyl}carbamoyl]-4-hydroxy-6- methylthio-1,2-dihydroguinoline,
(17) l-Methyl-2-oxo-3-[N-methyl-N-{3-(trifluoro- methyl)phenyl}carbamoyl]-4-hydroxy-6-methylthio-
1,2-dihydroquinoline,
(18) l-Methyl-2-oxo-3-[N-methyl-N-(4-nitrophenyl)- carbamoyl]-4-hydroxy-6-methylthio-1,2- dihydroquinoline,
(19) l-Methyl-2-oxo-3-[N-(4-aminophenyl)-4-methyl- carbamoyl]-4-hydroxy-6-methylthio-1,2-dihydro¬ quinoline,
( 20) l-Methyl-2-oxo-3-[N-[4-(formylamino)phenyl]- N-methylcarbamoyl]
-4-hydroxy-6-methylthio-1,2- dihydroquinoline,
(21) l-Methyl-2-oxo-3-{N-(l,3-benzodioxol-5-yl)-N- 


 methylcarbamoyl}-4-hydroxy-6-methylthio-1,2- dihydroquinoline,
(22) l-Methyl-2-oxo-3-{N-(2,4-difluorophenyl)-N- methylcarbamoyl}-4-hydroxy-6-raethylthio-l,2- dihydroquinoline and
(23) l-Methyl-2-oxo-3-{N-methγl-N-(4-methylphenyl)
■
 carbamoyl}-4-hydroxy-6-raethylthio-1,2-dihydro- quinoline.
8. A process for preparing a compound of the formula :
wherein R is lower alkyl or aryl which may have suitable substituent(s) , 2 R is hydroxy, protected hydroxy, lower alkoxy, halogen, amino, substituted amino, mercapto or protected mercapto,
R is hydrogen, lower alkyl, lower alkoxy(lower)alkyl or ar(lower)alkyl and R is hydrogen, or R 3 and R8 are linked together to form lower alkylene, R 4 i.s an organic group,
Z is 0 or S, and n is 0, 1 or 2, or a salt thereof, 


 which comprises
(1) reacting a compound of the formula
wherein R 1, R3, R8 and n are each as defined above, or a salt thereof with a compound of the formula :
wherein R and Z are each as defined above, and R is a leaving group, or a salt thereof to give a compound of the formula
wherein R , R , R , R , Z and n are each as defined above, or a salt thereof, or
(2) subjecting a compound of the formula : 


 -106-
wherein R , R , R , R , R and Z are each as defined above, or a salt thereof to oxidation reaction to give a compound of the formula :
1 2 3 4 8 wherein R , R , R , R , R and Z are each as defined above, and m is 1 or 2, or a salt thereof, or
(3) subjecting a compound of the formula
wherein R 1, R2, R3, R8, Z and n are each as defined above, or its reactive derivative at the carboxy group 


 -107-
or a salt thereof to amidation reaction to give a compound of the formula :
1 2 3 8 wherein R , R , R , R , Z and n are each as defined above, and g a group of the formula- : -CO-R is amidated carboxy, or a salt thereof, or
(4) subjecting a compound of the formula
1 2 3 8 wherein R , R , R , R , Z and n are each as defined above, and
4 . R E
=
L is pprrootteecctteedd ccarboxy, or a salt t .hheerreeooff ttoo eelliimmiinnaattio reaction of the
4 ccaarrbbooxxyy pprrooltective group in to give a compound of the formula
COOH

 -108-
T _r " 8 wherein R , R , R , R , Z and n are each as defined above, or a salt thereof, or
(5) subjecting a compound of the formula
1 2 3 8 wherein R , R , R , R , Z and n are each as defined above, and 4 R, is acyl having protected carboxy, or a salt thereof to elimination reaction of the carboxy protective group to give a compound of the formula :
1 2 3 8 wherein R , R , R , R , Z and n are each as defined above, and
R ,4 i.s acyl having carboxy. or a salt thereof, or
(6) reacting a compound of the formula

 wherein R , and n are each as defined above, or- a salt thereof with a compound of the formula
R
4
-CH(C0X
1
)
4 wherein R is as defined above, and
X is a leaving group, or a salt thereof to give a compound of the formula
wherein R 1, R4 and n are each as defined above, or a salt thereof, or
(7) subjecting a compound of the formula :
o
wherein R , R , R , R , Z and n are each as defined above, and X 2 i.s a leaving group, or a salt thereof to cyclization reaction to give a compound of the formula : 


 -110-

 wherein R 1, R3, R4, R8, Z and n are each as defined above, or a salt thereof, or
(8) subjecting a compound of the formula
wherein R , R , R , R , Z and n are each as defined above, or a salt thereof to halogenation reaction to give a compound of the formula :
wherein R , R , R , R , Z and n are each as defined above, and
2 R is halogen, or a salt thereof, or 


 (9) reacting a compound of the formula :
1 3 4 8 wherein R , R , R , R , Z and n are each as defined above, and 3 X is a leaving group, or a salt thereof with a compound of the formula :
H - R^
wherein _2 i 
s
s amino or substituted amino, or a salt thereof to give a compound of the formula
wherein R , R, , R , R , R , Z and n are each as defined above, or a salt thereof, or
(10) reacting a compound of the formula 

wherein R , R , R , R , Z, n and X are each as defined above, or a salt thereof with a compound of the formula
H^ - M
1
2 wherein R is protected mercapto, and
M
c
l is an alkali metal, or a salt thereof to give a compound of the formula
wherein R
1
, R
2
,, R
3
, R
4
, R
8
, Z and n are each as defined above, or a salt thereof, or
subjecting a compound of the formula

 1 2 3 4 8 wherein R , R^, R , R , R , Z and n are each as defined above, or a salt thereof to elimination reaction of the mercapto protective group to give a compound of the formula :
wherein R , R , R , R , Z and n are each as defined above, or a salt thereof, or
(12) reacting a compound of the formula
wherein R , R , R , R , Z, n and X are each as defined above, or a salt thereof with a compound of the formula
R: - M
<
wherein R ,2, is lower alkoxy and M is an alkali metal, or a salt thereof to give a compound of the formula 


 -114-
wherein R , R,, R , R , R , Z and n are each as defined above, or a salt thereof, or
(13) subjecting a compound of the formula
wherein R 1, R2, R3, R8, Z and n are each as defined above, and 4 R, is acyl having nitro, or a salt thereof to reduction reaction to give a compound of the formula :
wherein R 1 , R , R 3 , R 8 , Z and n are each as defined above , and 4 R is acyl having am o , 


 or a salt thereof, or
(14) subjecting a compound of the formula
1 T A O wherein R , R , R , R , R , Z and n are each as defined above, or a salt thereof to acylation reaction to give a compound of the formula :
1 2 3 4 8 wherein R , R , R , R , R , Z and n are each as defined above, and 4 .
R
f
 is acyl having acylamino, or a salt thereof.
9. A pharmaceutical composition which comprises, as an active ingredient, a compound of claim 1 or a pharmaceutically acceptable salt thereof in admixture with pharmaceutically acceptable carriers.
10. A use of a compound of claim 1 or a pharmaceutically acceptable salt thereof as immunomodulating agent, anti-inflammatory agent or anti-cancer agent. 


11. A method for the prophylactic or therapeutic treatment of inflammatory conditions, various pains, collagen diseases, autoimmune diseases, various immunity diseases or cancer which comprises administering a compound of claim 1 or a pharmaceutically acceptable salt thereof to human or animals.
12. A process for preparing a pharmaceutical composition which comprises admixing a compound of claim 1 or a
. pharmaceutically acceptable salt thereof with a pharmaceutically acceptable carrier. 

</CLAIMS>
</TEXT>
</DOC>
